IFNAR1 controls progression to cerebral malaria in children and CD8 + T cell brain pathology in plasmodium berghei-infected mice

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 5118-5127

  Ball, Elizabeth Ann ^a   Sambo, Maria Rosario ^a,b,c   Martins, Madalena ^a,d   Trovoada, Maria Jesus ^a,e   Benchimol, Carla ^c   Costa, Joao ^a   Goncalves, Ligia Antunes ^a   Coutinho, Antonio ^a   Penha Goncalves, Carlos ^a  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^b Universidade Agostinho Neto   (Angola)

^c Hospital Pediatrico David Bernardino   (Angola)

^d UNIVERSITY OF LISBON   (Portugal)

^e Centro National de Endemias   (Sao Tome and Principe)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MALARIA; BRAIN TISSUE; CD8+ T LYMPHOCYTE; CELL TRANSFER; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; GENETIC VARIABILITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUROPATHOLOGY; NEWBORN; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ANIMALS; BRAIN; BRAIN DISEASES; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION; GENOTYPE; HUMANS; INFANT; INFLAMMATION; MALARIA, CEREBRAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMODIUM BERGHEI; RECEPTOR, INTERFERON ALPHA-BETA; SPLEEN;

EID: 84877835932     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300114     Document Type: Article

References (48)

1. Issifou, S., E. Kendjo, M. A. Missinou, P. B. Matsiegui, A. Dzeing-Ella, F. A. Dissanami, M. Kombila, S. Krishna, and P. G. Kremsner. 2007. Differences in presentation of severe malaria in urban and rural Gabon. Am. J. Trop. Med. Hyg. 77: 1015-1019. (Pubitemid 351837785)
2. Mackintosh, C. L., J. G. Beeson, and K. Marsh. 2004. Clinical features and pathogenesis of severe malaria. Trends Parasitol. 20: 597-603. (Pubitemid 39446751)
3. Newton, C. R., and S. Krishna. 1998. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol. Ther. 79: 1-53. (Pubitemid 28318261)
4. Milner, D. A., Jr. 2010. Rethinking cerebral malaria pathology. Curr. Opin. Infect. Dis. 23: 456-463.
5. Carvalho, L. J. 2010. Murine cerebral malaria: how far from human cerebral malaria Trends Parasitol. 26: 271-272.
6. Craig, A. G., G. E. Grau, C. Janse, J. W. Kazura, D. Milner, J. W. Barnwell, G. Turner, and J. Langhorne; participants of the Hinxton Retreat meeting on Animal Models for Research on Severe Malaria. 2012. The role of animal models for research on severe malaria. PLoS Pathog. 8: e1002401.
7. de Souza, J. B., J. C. Hafalla, E. M. Riley, and K. N. Couper. 2010. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 137: 755-772.
8. Rénia, L., A. C. Gruner, and G. Snounou. 2010. Cerebral malaria: in praise of epistemes. Trends Parasitol. 26: 275-277.
9. Riley, E. M., K. N. Couper, H. Helmby, J. C. Hafalla, J. B. de Souza, J. Langhorne, W. B. Jarra, and F. Zavala. 2010. Neuropathogenesis of human and murine malaria. Trends Parasitol. 26: 277-278.
10. + T cells in experimental cerebral malaria. J. Immunol. 169: 6369-6375. (Pubitemid 36903485)
11. + T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology 114: 7-12. (Pubitemid 27022698)
12. Driss, A., J. M. Hibbert, N. O. Wilson, S. A. Iqbal, T. V. Adamkiewicz, and J. K. Stiles. 2011. Genetic polymorphisms linked to susceptibility to malaria. Malar. J. 10: 271.
13. Aucan, C., A. J. Walley, B. J. Hennig, J. Fitness, A. Frodsham, L. Zhang, D. Kwiatkowski, and A. V. Hill. 2003. Interferon-Alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in the Gambia. Genes Immun. 4: 275-282. (Pubitemid 39562127)
14. Khor, C. C., F. O. Vannberg, S. J. Chapman, A. Walley, C. Aucan, H. Loke, N. J. White, T. Peto, L. K. Khor, D. Kwiatkowski, et al. 2007. Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus. Genes Immun. 8: 570-576. (Pubitemid 350011689)
15. Diop, G., T. Hirtzig, H. Do, C. Coulonges, A. Vasilescu, T. Labib, J. L. Spadoni, A. Therwath, M. Lathrop, F. Matsuda, and J. F. Zagury. 2006. Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort. Biomed. Pharmacother. 60: 569-577. (Pubitemid 44635089)
16. Ito, T., H. Kanzler, O. Duramad, W. Cao, and Y. J. Liu. 2006. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107: 2423-2431. (Pubitemid 43345563)
17. Prinz, M., H. Schmidt, A. Mildner, K. P. Knobeloch, U. K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, et al. 2008. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28: 675-686.
18. deWalick, S., F. H. Amante, K. A. McSweeney, L. M. Randall, A. C. Stanley, A. Haque, R. D. Kuns, K. P. MacDonald, G. R. Hill, and C. R. Engwerda. 2007. Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria. J. Immunol. 178: 6033-6037. (Pubitemid 46717381)
19. + dendritic cells. Proc. Natl. Acad. Sci. USA 105: 14509-14514.
20. O'Connell, R. M., S. K. Saha, S. A. Vaidya, K. W. Bruhn, G. A. Miranda, B. Zarnegar, A. K. Perry, B. O. Nguyen, T. F. Lane, T. Taniguchi, et al. 2004. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200: 437-445. (Pubitemid 39121901)
21. Stockinger, S., and T. Decker. 2008. Novel functions of type I interferons revealed by infection studies with Listeria monocytogenes. Immunobiology 213: 889-897.
22. Sharma, S., R. B. DeOliveira, P. Kalantari, P. Parroche, N. Goutagny, Z. Jiang, J. Chan, D. C. Bartholomeu, F. Lauw, J. P. Hall, et al. 2011. Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 35: 194-207.
23. Haque, A., S. E. Best, A. Ammerdorffer, L. Desbarrieres, M. M. de Oca, F. H. Amante, F. de Labastida Rivera, P. Hertzog, G. M. Boyle, G. R. Hill, and C. R. Engwerda. 2011. Type I interferons suppress CD4 T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur. J. Immunol. 41: 2688-2698.
24. e Pinto, E. A., and J. G. Alves. 2008. The causes of death of hospitalized children in Angola. Trop. Doct. 38: 66-67.
25. Sambo, M. R., M. J. Trovoada, C. Benchimol, V. Quinhentos, L. Gonçalves, R. Velosa, M. I. Marques, N. Sepu'lveda, T. G. Clark, S. Mustafa, et al. 2010. Transforming growth factor beta 2 and heme oxygenase 1 genes are risk factors for the cerebral malaria syndrome in Angolan children. PLoS ONE 5: e11141.
26. Greenwood, B. M., and J. R. Armstrong. 1991. Comparison of two simple methods for determining malaria parasite density. Trans. R. Soc. Trop. Med. Hyg. 85: 186-188.
27. Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)
28. Luna, A., and K. K. Nicodemus. 2007. snp.plotter: an R-based SNP/haplotype association and linkage disequilibrium plotting package. Bioinformatics 23: 774-776. (Pubitemid 46554733)
29. González, J. R., L. Armengol, X. Solé, E. Guinó, J. M. Mercader, X. Estivill, and V. Moreno. 2007. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 23: 644-645. (Pubitemid 46522604)
30. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
31. Franke-Fayard, B., H. Trueman, J. Ramesar, J. Mendoza, M. van der Keur, R. van der Linden, R. E. Sinden, A. P. Waters, and C. J. Janse. 2004. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol. 137: 23-33. (Pubitemid 38987939)
32. Pamplona, A., A. Ferreira, J. Balla, V. Jeney, G. Balla, S. Epiphanio, A. Chora, C. D. Rodrigues, I. P. Gregoire, M. Cunha-Rodrigues, et al. 2007. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 13: 703-710. (Pubitemid 46889755)
33. Epiphanio, S., S. A. Mikolajczak, L. A. Gonçalves, A. Pamplona, S. Portugal, S. Albuquerque, M. Goldberg, S. Rebelo, D. G. Anderson, A. Akinc, et al. 2008. Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host Microbe 3: 331-338. (Pubitemid 351635999)
34. Ferreira, A., I. Marguti, I. Bechmann, V. Jeney, A. Chora, N. R. Palha, S. Rebelo, A. Henri, Y. Beuzard, and M. P. Soares. 2011. Sickle hemoglobin confers tolerance to Plasmodium infection. Cell 145: 398-409.
35. Zhou, J., J. D. Huang, V. K. Poon, D. Q. Chen, C. C. Chan, F. Ng, X. Y. Guan, R. M. Watt, L. Lu, K. Y. Yuen, and B. J. Zheng. 2009. Functional dissection of an IFN-Alpha/beta receptor 1 promoter variant that confers higher risk to chronic hepatitis B virus infection. J. Hepatol. 51: 322-332.
36. Song, H., N. T. Xuan, N. L. Toan, V. Q. Binh, A. B. Boldt, P. G. Kremsner, and J. F. Kun. 2008. Association of two variants of the interferon-Alpha receptor-1 gene with the presentation of hepatitis B virus infection. Eur. Cytokine Netw. 19: 204-210.
37. Vigário, A. M., E. Belnoue, A. C. Gruner, M. Mauduit, M. Kayibanda, J. C. Deschemin, M. Marussig, G. Snounou, D. Mazier, I. Gresser, and L. Rénia. 2007. Recombinant human IFN-Alpha inhibits cerebral malaria and reduces parasite burden in mice. J. Immunol. 178: 6416-6425. (Pubitemid 46717425)
38. Medzhitov, R., D. S. Schneider, and M. P. Soares. 2012. Disease tolerance as a defense strategy. Science 335: 936-941.
39. Erdman, L. K., and K. C. Kain. 2011. Taking the sting out of malaria. Immunity 35: 149-151.
40. + T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 170: 2221-2228. (Pubitemid 36197447)
41. + T cells is required for the development of experimental cerebral malaria. J. Immunol. 186: 6148-6156.
42. Marrack, P., J. Kappler, and T. Mitchell. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189: 521-530.
43. Galea, I., M. Bernardes-Silva, P. A. Forse, N. van Rooijen, R. S. Liblau, and V. H. Perry. 2007. An antigen-specific pathway for CD8 T cells across the bloodbrain barrier. J. Exp. Med. 204: 2023-2030. (Pubitemid 47360864)
44. Miu, J., N. H. Hunt, and H. J. Ball. 2008. Predominance of interferon-related responses in the brain during murine malaria, as identified by microarray analysis. Infect. Immun. 76: 1812-1824. (Pubitemid 351656115)
45. Stewart, T. A. 2003. Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases. Cytokine Growth Factor Rev. 14: 139-154. (Pubitemid 36389527)
46. + T cell response during cross-priming. J. Immunol. 176: 4682-4689.
47. + T cell accumulation within the brain. J. Immunol. 189: 968-979.
48. Johns, T. G., I. R. Mackay, K. A. Callister, P. J. Hertzog, R. J. Devenish, and A. W. Linnane. 1992. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta. J. Natl. Cancer Inst. 84: 1185-1190.